Skip to main content
Journal of Ophthalmic Inflammation and Infection
Fig. 3 | Journal of Ophthalmic Inflammation and Infection

Fig. 3

From: Resuming anti-TNF therapy after development of miliary tuberculosis in Behcet’s disease-related uveitis: a case report

Fig. 3

Imaging findings before and after resuming TNF inhibitor. After discontinuation of TNF inhibitor (adalimumab), fundus photograph (a) and OCT image (b) show worsening of vitreous opacity and macular oedema in left eye. After resuming TNF inhibitor (infliximab), fundus photograph (c) and OCT image (d) show improvement of vitreous opacity and macular oedema. After resuming TNF inhibitor (infliximab), fluorescein angiography shows no remarkable findings in right eye (e), but depicts diffuse vascular leakage at the posterior pole and periphery retina in left eye (f)

Back to article page